Arginine-Silicate Inositol Complex Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing arginine-silicate complexes (ASI) result in inconsistent particle shapes and sizes, leading to clumping and reduced solubility issues, which affect the consistency and effectiveness of the final product.
Innovation Solution
The process involves modifying the production method by controlling the temperature and particle size distribution to reduce clumping and increase solubility, including heating the arginine-silicate-inositol mixture to specific temperatures, using spray drying to maintain the complex in solution, and optimizing particle size and shape distributions to prevent aggregation and improve solubility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional production methods are used to manufacture ASI powder, then production is simpler and faster, but the particles clump and solubility decreases
Solution Approach 1:
The patent applies parameter changes by controlling temperature (heating to 80-100°C for 5-30 minutes) and pH (adjusting to specific ranges) during the complex formation process. These parameter modifications ensure consistent particle morphology and size distribution, which directly improves solubility and prevents clumping without requiring fundamentally new production equipment
Solution Approach 2:
The patent employs preliminary action by pre-forming the arginine-silicate-inositol complex under controlled conditions before final product formation. The method includes preliminary heating and pH adjustment steps that prepare the mixture for optimal complex formation, ensuring uniform particle characteristics that prevent subsequent clumping and maintain solubility
2Manufacturing precision
If conventional production methods are used, then manufacturing is easier, but particle shape and size are inconsistent leading to clumping
Solution Approach 1:
The patent achieves consistent particle uniformity by implementing specific parameter controls including temperature (80-100°C), pH ranges, and reaction time (5-30 minutes). These controlled parameters ensure reproducible particle morphology and size distribution across production batches, eliminating the inconsistency that causes clumping while maintaining manufacturing feasibility
Solution Approach 2:
The patent incorporates feedback mechanisms by monitoring and adjusting pH and temperature during the complex formation process. This real-time control ensures that particle formation occurs under optimal conditions, producing uniform particles with consistent size and shape that resist clumping, while allowing for adjustments to maintain manufacturing efficiency
3Reliability
If particle size is increased to reduce clumping, then solubility improves, but particle surface area decreases affecting dissolution rate
Solution Approach 1:
The patent resolves this contradiction by controlling the complex formation parameters (temperature, pH, time) to produce particles with optimized size distribution and morphology. The controlled process generates particles that have sufficient size to reduce clumping but maintain appropriate surface area characteristics for rapid dissolution, achieving both solubility improvement and fast dissolution rate simultaneously
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified process produces ASI products with reduced or eliminated clumping and increased solubility, enhancing their stability and usability in nutritional and pharmaceutical applications.
Implementation Method 1
heating the arginine-silicate-inositol mixture to specific temperatures
Implementation Method 2
using spray drying to maintain the complex in solution
Data Source
AI summary
Methods of manufacturing inositol-stabilized arginine-silicate (“ASI”) complexes with reduced or eliminated clumping and with increased solubility.


